Circulating inflammatory mediators predict shock and mortality in febrile patients with microbial infection (Q40562200)

21 September 2017

Circulating inflammatory mediators predict shock and mortality in febrile patients with microbial infection (English)

1 reference

21 September 2017

A B J Groeneveld

1

1 reference

21 September 2017

A N Tacx

2

1 reference

21 September 2017

A W J Bossink

3

1 reference

21 September 2017

G J van Mierlo

4

1 reference

21 September 2017

C E Hack

5

1 reference

21 September 2017

1 February 2003

1 reference

21 September 2017

10

1 reference

inferred from page(s)

published in

Clinical Immunology

1 reference

21 September 2017

106

1 reference

21 September 2017

2

1 reference

21 September 2017

106-115

1 reference

Fever in hospitalized patients. With special reference to the medical service

21 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

Interleukin-8 in serum and cerebrospinal fluid from patients with meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

Compartmentalized IL-8 and elastase release within the human lung in unilateral pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

Local Pseudomonas instillation induces contralateral lung injury and plasma cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

Passive immunization against tumor necrosis factor-alpha impairs host defense during pneumococcal pneumonia in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

Inflammatory cytokine response in patients with septic shock secondary to generalized peritonitis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

The value of immune modulating parameters in predicting the progression from peritonitis to septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

Prediction of microbial infection and mortality in medical patients with fever: plasma procalcitonin, neutrophilic elastase-alpha1-antitrypsin, and lactoferrin compared with clinical variables

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

Elevated plasma levels of the anaphylatoxins C3a and C4a are associated with a fatal outcome in sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

High circulating levels of interleukin-6 in patients with septic shock: Evolution during sepsis, prognostic value, and interplay with other cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

Patterns of cytokines, plasma endotoxin, plasminogen activator inhibitor, and acute-phase proteins during the treatment of severe sepsis in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

Complement activation and polymorphonuclear neutrophil leukocyte elastase in sepsis. Correlation with severity of disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

Serum Cytokine Levels in Human Septic Shock

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

Secretory non-pancreatic phopholipase A2 in severe sepsis: relation to endotoxin, cytokines and thromboxane B2.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

Sepsis and serum cytokine concentrations.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

Cytokine profile and correlation to the APACHE III and MPM II scores in patients with sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

Predictive value of nuclear factor kappaB activity and plasma cytokine levels in patients with sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

Complement activation in patients with sepsis is in part mediated by C-reactive protein

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

Protective effects of C5a blockade in sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

Role of C5a in multiorgan failure during sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

Lipid mediators in the pathophysiology of critical illness

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

The effect of C1-esterase inhibitor in definite and suspected streptococcal toxic shock syndrome. Report of seven patients

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

Phase I trial of the recombinant soluble complement receptor 1 in acute lung injury and acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

Immunological therapy of sepsis: experimental therapies

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

Randomized, placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: The RAMSES Study

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

Blockade of tumor necrosis factor reduces lipopolysaccharide lethality, but not the lethality of cecal ligation and puncture

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

Prediction of mortality in febrile medical patients: How useful are systemic inflammatory response syndrome and sepsis criteria?

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

Sensitive ELISA for interleukin-6. Detection of IL-6 in biological fluids: synovial fluids and sera

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

Local inflammatory responses following bronchial endotoxin instillation in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

Anti-TNF treatment of baboons with sepsis reduces TNF-alpha, IL-6 and IL-8, but not the degree of complement activation

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

Role of the classical pathway of complement activation in experimentally induced polymicrobial peritonitis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

Phospholipase A2 from plasma of patients with septic shock is associated with high-density lipoproteins and C3 anaphylatoxin: some implications for its functional role

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

Both C3a and C3a(desArg) regulate interleukin-6 synthesis in human peripheral blood mononuclear cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

Interleukin-6 is required for a protective immune response to systemic Escherichia coli infection

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

Gender differences in human sepsis.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900025-6

7 January 2021

10.1016/S1521-6616(02)00025-6

Identifiers

DOI

1 reference

21 September 2017

1 reference